It was reported that the procedure was performed to treat a lesion in the heavily tortuous and calcified mid to distal right coronary artery (rca).The first xience skypoint stent delivery system was advanced to the target lesion; however, the device was unable to cross to the target lesion due to the patient anatomy.The device was removed from the anatomy without difficulty and a second xience skypont was used.The second xience skypoint was advanced; however, this one was also unable to cross due to the patient anatomy and the proximal shaft kinked.The device was removed without difficulty, but separated at the kink, at a location outside the patient anatomy.Both separated segments were easily removed from the patient anatomy.There was no adverse patient effect and no clinically significant delay.No additional information was provided.
|
The device was returned for analysis.The reported deformation due to compressive stress (shaft kink) and material separation were confirmed.The reported failure to advance could not be replicated in a testing environment as it was related to operational context of the procedure.Additionally, biological matter was noted at the separated portion of the hypotube during return analysis of the device.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no similar incidents from this lot.The investigation determined the reported difficulties appear to be related to circumstances of the procedure as it is likely the device interacted with the heavily tortuous and calcified artery causing the reported failure to advance.Continued resistance with the difficult anatomy during the attempted advancement ultimately resulted in a shaft kink and subsequent material separation.Additionally, regarding the noted biological matter at the separated portion of the hypotube, the account indicated that no patient injury was noted and no additional intervention was performed to treat patient injury.It is suspected that the tissue is due to advancing through the patient anatomy; however, this cannot be confirmed.There is no indication of a product quality issue with respect to manufacture, design or labeling.
|